Article Text

Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy
  1. Elena Gonzalez-Rey1,
  2. Per Anderson2,
  3. Mario Delgado2
  1. 1
    Departamento de Bioquimica Medica y Biologia Molecular, Universidad de Sevilla, Sevilla 41009, Spain
  2. 2
    Instituto de Parasitologia y Biomedicina, Consejo Superior de Investigaciones Cientificas, Granada 18100, Spain
  1. Mario Delgado, Instituto de Parasitologia y Biomedicina, CSIC, Avd. Conocimiento, PT Ciencias de la Salud, Granada 18100, Spain; mdelgado{at}


Identification of the factors that regulate the immune tolerance and control the appearance of exacerbated inflammatory conditions is crucial for the development of new therapies of autoimmune diseases. Some neuropeptides and hormones have emerged as endogenous agents that participate in the regulation of the processes that ensure self-tolerance. Among them, the vasoactive intestinal peptide (VIP), a well-characterised endogenous anti-inflammatory neuropeptide, has shown therapeutic potential for a variety of immune disorders. Here we examine the latest research findings, which indicate that VIP participates in maintaining immune tolerance in two distinct ways: by regulating the balance between pro-inflammatory and anti-inflammatory factors, and by inducing the emergence of regulatory T cells with suppressive activity against autoreactive T cell effectors.

Statistics from


  • Funding: This work was supported by grants from the Spanish Ministry of Health, the NIH and Junta de Andalucia.

  • Competing interests: None declared.

  • Abbreviations:
    antigen-presenting cells
    dendritic cells
    protein kinase A
    toll-like receptors
    T regulatory
    T regulatory 1
    vasoactive intestinal peptide

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.